Frontiers in Cellular and Infection Microbiology (Apr 2022)
Integrins as Therapeutic Targets for SARS-CoV-2
- Timothy E. Gressett,
- Timothy E. Gressett,
- Timothy E. Gressett,
- Danielle Nader,
- Juan Pablo Robles,
- Tione Buranda,
- Steven W. Kerrigan,
- Gregory Bix,
- Gregory Bix,
- Gregory Bix
Affiliations
- Timothy E. Gressett
- Tulane University School of Medicine, Clinical Neuroscience Research Center (CNRC), New Orleans, LA, United States
- Timothy E. Gressett
- Department of Neurology, Tulane University School of Medicine, New Orleans, LA, United States
- Timothy E. Gressett
- Tulane Brain Institute, Tulane University, New Orleans, LA, United States
- Danielle Nader
- RCSI University of Medicine and Health Sciences, School of Pharmacy and Biomolecular Sciences (PBS), Dublin, Ireland
- Juan Pablo Robles
- Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Juriquilla, Mexico
- Tione Buranda
- University of New Mexico Health Sciences Center (HSC), Department of Pathology, Albuquerque, NM, United States
- Steven W. Kerrigan
- RCSI University of Medicine and Health Sciences, School of Pharmacy and Biomolecular Sciences (PBS), Dublin, Ireland
- Gregory Bix
- Tulane University School of Medicine, Clinical Neuroscience Research Center (CNRC), New Orleans, LA, United States
- Gregory Bix
- Department of Neurology, Tulane University School of Medicine, New Orleans, LA, United States
- Gregory Bix
- Tulane Brain Institute, Tulane University, New Orleans, LA, United States
- DOI
- https://doi.org/10.3389/fcimb.2022.892323
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
